Abeona Therapeutics Inc Stock Forecast, Predictions & Price Target

Analyst price target for ABEO

Based on 2 analysts offering 12 month price targets for Abeona Therapeutics Inc.
Min Forecast
Avg Forecast
Max Forecast

Should I buy or sell ABEO stock?

Based on 2 analysts offering ratings for Abeona Therapeutics Inc.
Strong Buy
1 analysts 50%
0 analysts 0%
1 analysts 50%
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ABEO stock forecasts and price targets.

ABEO stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
SVB Leerink
Bottom 1%
Cantor Fitzgerald
Top 5%
Strong BuyMaintains$40.00+1,323.49%2022-11-08Find out why

1 of 1

ABEO vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
GLTO$1.93$11.00+469.95%Strong Buy
LTRN$4.62$11.00+138.10%Strong Buy

Abeona Therapeutics Stock Forecast FAQ

Is Abeona Therapeutics Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: ABEO) stock is to Buy ABEO stock.

Out of 2 analysts, 1 (50%) are recommending ABEO as a Strong Buy, 0 (0%) are recommending ABEO as a Buy, 1 (50%) are recommending ABEO as a Hold, 0 (0%) are recommending ABEO as a Sell, and 0 (0%) are recommending ABEO as a Strong Sell.

If you're new to stock investing, here's how to buy Abeona Therapeutics stock.

What is ABEO's Price Target?

According to 2 Wall Street analysts that have issued a 1 year ABEO price target, the average ABEO price target is $23.00, with the highest ABEO stock price forecast at $40.00 and the lowest ABEO stock price forecast at $6.00.

On average, Wall Street analysts predict that Abeona Therapeutics's share price could reach $23.00 by Nov 14, 2023. The average Abeona Therapeutics stock price prediction forecasts a potential upside of 718.51% from the current ABEO share price of $2.81.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.